Varengold Bank AG
- WKN: 547930
- ISIN: DE0005479307
- Land: Germany
Nachricht vom 13.07.2021 | 14:00
Varengold Bank AG continues growth in the 1st half of 2021
DGAP-News: Varengold Bank AG
/ Key word(s): Half Year Results/Miscellaneous
Hamburg, 13/07/2021 - Varengold Bank AG [ISIN: DE0005479307] continues to grow. In the first half of 2021, the Hamburg-based financial services provider almost doubled its net income to EUR 24.75 million (30 June 2020: EUR 12.97 million). Varengold Bank was able to increase its earnings before taxes (EBT) by 400% to EUR 8.12 million (30 June 2020: EUR 1.63 million). Once again, Transaction Banking proved to be a key growth driver. Within Marketplace Banking, the bank's second strategic growth market, there is further reason to be optimistic about the future: within the areas of "Lending" and "Fronting/Banking as a Service (BaaS)", additional customers have been acquired and the product range has been expanded.
To manage its growth, Varengold Bank is continuously working on refining its profile as an employer, in order to gain a competitive edge and attract the best professionals. This has proven to be successful. As of 30 June 2021, the Bank employed 102 highly qualified staff in Hamburg, Sofia and London. At the end of 2020, Varengold employed 91 staff at all three locations.
Varengold Bank continues to pursue a conservative risk policy and will continue to use part of its earnings to hedge risks in the first half of 2021. When considering its business development during the first half of 2021 as well as its well-filled transaction pipeline, the Bank continues to expect to achieve the forecasted EBT of EUR 16.4 million for 2021.
About Varengold Bank AG
Ms. Sanja Schultz-Szabo (Head of Corporate Development)
|Company:||Varengold Bank AG|
|Große Elbstraße 39|
|Phone:||+49 (0)40 / 668649-0|
|Fax:||+49 (0)40 / 668649-49|
|Listed:||Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt (Basic Board), Munich, Stuttgart|
|EQS News ID:||1218370|
|End of News||DGAP News Service|
Varengold Bank AG achieves another strong resu ...
Varengold Bank AG: In Schwebeliegen schaukeln ...
Varengold Bank AG continues growth in the 1st ...
Varengold Bank AG: Forecast for the 2021 finan ...
Varengold Bank AG records strong growth in Q1 2021
GBC im Fokus
IGEA Pharma N.V. Realignment to CBD extraction
The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.
Der AKTIONÄR News
28. November 08:00 E-Mobilität Batterie Index: Unaufhaltsam
28. November 08:19 DAX-Wochenausblick: Omikron verdirbt die Jahresendrally – oder?
28. November 08:30 TSI USA: 100 Prozent Plus? Keine Besonderheit!
28. November 09:29 Mit System zu den Top-Performern wie Tesla oder Nvidia
28. November 10:00 Biotech-Kursexplosion voraus – dieser Hot-Stock bläst jetzt zum ...
Original-Research: 3U HOLDING AG (von GSC Research GmbH): Halten
26. November 2021